Teladoc Health/$TDOC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Teladoc Health
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
Ticker
$TDOC
Sector
Primary listing
NYSE
Employees
5,060
Headquarters
Website
Teladoc Health Metrics
BasicAdvanced
$1.4B
-
-$1.19
1.85
-
Price and volume
Market cap
$1.4B
Beta
1.85
52-week high
$15.21
52-week low
$6.35
Average daily volume
5.4M
Financial strength
Current ratio
2.671
Quick ratio
2.274
Long term debt to equity
72.089
Total debt to equity
72.784
Interest coverage (TTM)
-8.07%
Profitability
EBITDA (TTM)
43.431
Gross margin (TTM)
70.26%
Net profit margin (TTM)
-8.16%
Operating margin (TTM)
-7.22%
Effective tax rate (TTM)
10.76%
Revenue per employee (TTM)
$500,000
Management effectiveness
Return on assets (TTM)
-3.57%
Return on equity (TTM)
-14.18%
Valuation
Price to revenue (TTM)
0.524
Price to book
0.95
Price to tangible book (TTM)
-5.55
Price to free cash flow (TTM)
8.815
Free cash flow yield (TTM)
11.34%
Free cash flow per share (TTM)
0.871
Growth
Revenue change (TTM)
-2.57%
Earnings per share change (TTM)
-80.13%
3-year revenue growth (CAGR)
4.41%
10-year revenue growth (CAGR)
45.79%
3-year earnings per share growth (CAGR)
-73.13%
10-year earnings per share growth (CAGR)
-24.10%
What the Analysts think about Teladoc Health
Analyst ratings (Buy, Hold, Sell) for Teladoc Health stock.
Bulls say / Bears say
Integrated Care segment revenue grew 4% year-over-year to $391.5 million in Q2 2025, with a robust 14.7% adjusted EBITDA margin, highlighting continued momentum in its high-margin chronic care services. (SEC EDGAR)
Teladoc used $550.6 million in cash during Q2 2025 to retire convertible senior notes due that quarter, significantly lowering near-term debt and improving its balance sheet. (SEC EDGAR)
Teladoc and LifeMD partnered with Gifthealth (Eli Lilly’s pharmacy partner) to deliver the weight-loss drug Zepbound directly to qualified patients, expanding into the fast-growing weight management space. (Reuters)
BetterHelp revenue fell 9% to $240.4 million in Q2 2025, with an adjusted EBITDA margin of just 4.9%, underlining persistent structural issues in its consumer mental health business. (SEC EDGAR)
Teladoc posted a net loss of $32.7 million for Q2 2025, continuing to operate at a loss despite strong results in its Integrated Care segment. (SEC EDGAR)
Data summarised monthly by Lightyear AI. Last updated on 10 Sept 2025.
Teladoc Health Financial Performance
Revenues and expenses
Teladoc Health Earnings Performance
Company profitability
Teladoc Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Teladoc Health stock?
Teladoc Health (TDOC) has a market cap of $1.4B as of September 15, 2025.
What is the P/E ratio for Teladoc Health stock?
The price to earnings (P/E) ratio for Teladoc Health (TDOC) stock is 0 as of September 15, 2025.
Does Teladoc Health stock pay dividends?
No, Teladoc Health (TDOC) stock does not pay dividends to its shareholders as of September 15, 2025.
When is the next Teladoc Health dividend payment date?
Teladoc Health (TDOC) stock does not pay dividends to its shareholders.
What is the beta indicator for Teladoc Health?
Teladoc Health (TDOC) has a beta rating of 1.85. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.